|
⚲
|
| Keyboard |
| Nissen Torben Straight
✚
|
|
|---|---|
| CIK # | 0001746647 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001746647] | |
| 4 | [0001746647] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nissen Torben Straight | |
| Axcella Health Inc | |
| Rubius Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Axcella Health Inc AXLA
Stock Option (Right to Buy) · derivative
|
2022-11-16 | Grant | 40,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2019-07-24 | Option exercise | 175,000 | $0.18 | 31,500 |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2019-07-24 | Option exercise | 32,146 | $0.19 | 6,108 |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2019-07-24 | Option exercise | 32,146 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2019-07-24 | Option exercise | 175,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2019-04-08 | Sell | 2,100 | $20.00 | 42,000 |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2019-04-05 | Sell | 12,096 | $20.00 | 241,920 |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2019-04-03 | Sell | 500 | $20.00 | 10,000 |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2019-01-31 | Grant | 175,000 | $0.00 |